Hospital News and Research

RSS

New test can detect drug abuse faster

A new test for club drugs like ketamine can detect low levels of drugs in urine and plasma, making it faster, easier and cheaper to identify them. The authors of the study, published in Journal of Chromatography B, say it could give authorities the boost they need to keep up with trends drug (ab)use.

26 Nov 2015

Obese children with NAFLD not meeting recommended physical activity levels

In a new study published today in the journal Nutrients, research from the University of Surrey and the Children's Liver Disease Foundation has found that both obese children and those with Non-Alcoholic Fatty Liver Disease (NAFLD) are not meeting the UK recommendations for a variety of vitamins and minerals.

26 Nov 2015

Oxytocin hormone strengthens social ties

Nowadays, much emphasis is placed on sustainability. The degree to which people are willing to donate their own money for this depends on their level of oxytocin. Scientists at the University of Bonn Hospital have discovered that the willingness to donate increases with the quantity of this bonding hormone. However, oxytocin only has an effect with regard to social sustainability projects. The hormone does not increase the ability to participate in the case of purely environmentally oriented projects.

26 Nov 2015

Medical professionals compare different treatment options for Neuromyelitis optica

In the course of a study conducted throughout Germany, medical professionals have compared different treatment methods for Neuromyelitis optica, an inflammatory disease of the central nervous system. It turned out that the best results were not achieved with conventional steroid therapy.

26 Nov 2015

Lightpoint Medical obtains 2.4M Euro grant to carry out breast cancer clinical trial

Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that it has received a 2.4M Euro grant from the European Commission as part of the Horizon 2020 European Union Framework Programme for Research and Innovation, enabling the company to carry out a large-scale clinical trial in breast cancer.

26 Nov 2015

Chikungunya may cause severe brain infection

The mosquito-borne virus chikungunya may lead to severe brain infection and even death in infants and people over 65, according to a new study that reviewed a chikungunya outbreak on Reunion Island off the coast of Madagascar in 2005-2006.

26 Nov 2015

New drug combination shows promise in treating men with metastatic prostate cancer

A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.

26 Nov 2015

Research reveals MECP2 Duplication Syndrome can be reversed

The methyl CpG binding protein 2 gene (MECP2) produces a protein of the same name, the level of which is critical for normal brain function. Mutations leading to protein under-expression cause Rett Syndrome while gene duplication causing over-expression lead to MECP2 Duplication Syndrome. Both disorders are severely debilitating childhood neurological diseases.

26 Nov 2015

Researchers successfully combine antibody-drug conjugate with immunotherapy to attack breast cancer cells

To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years. Researchers from the University and University Hospital Basel have now for the first time successfully combined such an antibody-drug conjugate with a therapy that stimulates the immune system to attack tumor cells.

26 Nov 2015

Researchers begin landmark clinical study to restore normal insulin secretion in people with type 1 diabetes

Investigators at Montreal's Lady Davis Institute at the Jewish General Hospital and McGill University Health Centre have announced the start of a landmark clinical study aimed at restoring normal insulin secretion in people with longstanding type 1 diabetes.

26 Nov 2015

Early occlusion key to preventing aneurysmal subarachnoid haemorrhage rebleeding

Researchers stress the need for early occlusion of subarachnoid aneurysms to prevent death from rebleeding.

25 Nov 2015

TSO3, Getinge Infection Control ink global distributor agreement for STERIZONE VP4 Sterilizer

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, has granted Getinge Infection Control AB, a global leader in infection control solutions, exclusive global distributor rights to its FDA-cleared, STERIZONE VP4 Sterilizer for US$7.5 million, plus performance minimums

25 Nov 2015

New drug may show promise against resistant melanomas

A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute may show promise for treating skin cancers that are resistant or unresponsive to today's leading therapies.

25 Nov 2015

Allergan, Rugen Therapeutics collaborate to discover and develop novel therapies for ASD and OCD

Allergan plc, a leading global pharmaceutical company, and Rugen Therapeutics, a start-up biotechnology company focused on the development of novel treatments for unmet CNS disorders and funded by the F-Prime Biomedical Research Initiative, today announced that they have entered into an exclusive collaboration to support the discovery and development of novel therapies for Autism Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD).

25 Nov 2015

WPI researchers awarded $1.3 million NIH grant to study use of copper to battle bacterial invader

Copper is an essential micronutrient that all organisms need to maintain healthy metabolism. But unless it is bound to proteins, copper is also toxic to cells. With a $1.3 million award from the National Institutes of Health, researchers at Worcester Polytechnic Institute will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a leading cause of hospital-associated infections that is increasingly resistant to antibiotics, with the hope of discovering new drug targets that might allow cells in the body to use copper to fight back against this bacterial invader.

25 Nov 2015

People with viral infections and identical gene mutations may be prone to hyperinflammatory disorder

A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a study in The Journal of Infectious Diseases.

25 Nov 2015

Risk of developing visceral leishmaniasis much higher in transplant patients

Researchers from Spain have analysed the prevalence of leishmaniasis among the population of organ transplant recipients. The findings of this study, published in the journal 'PLoS Neglected Tropical Disease', confirm that the risk of developing visceral leishmaniasis ‑the most severe form of the disease which can pose life-threatening complications‑ is more than one hundred times greater in transplant patients living in areas of disease outbreak.

25 Nov 2015

Infants below age 1 at risk of serious physical abuse

Infants under the age of 12 months are most at risk of serious physical abuse, reveals a large study of severely injured children published online in Emergency Medicine Journal.

25 Nov 2015

UNC study reveals how specific schizophrenia symptoms linked to distinct brain circuits

Schizophrenia, a severe mental disorder affecting about one in 100 people, is notoriously difficult to diagnose and treat, in large part because it manifests differently in different people. A new study published today in Molecular Neuropsychiatry helps explain why.

25 Nov 2015

Therapeutic hypothermia after cardiac arrest improves survival and neurological outcomes

Survivors of cardiac arrest who remain in comas have better survival and neurological outcomes when their body temperatures are lowered, according to new research by Dr. Sarah Perman at the University of Colorado Anschutz Medical Campus.

25 Nov 2015

Hospital News and Research

New test can detect drug abuse faster

Obese children with NAFLD not meeting recommended physical activity levels

Oxytocin hormone strengthens social ties

Medical professionals compare different treatment options for Neuromyelitis optica

Lightpoint Medical obtains 2.4M Euro grant to carry out breast cancer clinical trial

Chikungunya may cause severe brain infection

New drug combination shows promise in treating men with metastatic prostate cancer

Research reveals MECP2 Duplication Syndrome can be reversed

Researchers successfully combine antibody-drug conjugate with immunotherapy to attack breast cancer cells

Researchers begin landmark clinical study to restore normal insulin secretion in people with type 1 diabetes

Early occlusion key to preventing aneurysmal subarachnoid haemorrhage rebleeding

TSO3, Getinge Infection Control ink global distributor agreement for STERIZONE VP4 Sterilizer

New drug may show promise against resistant melanomas

Allergan, Rugen Therapeutics collaborate to discover and develop novel therapies for ASD and OCD

WPI researchers awarded $1.3 million NIH grant to study use of copper to battle bacterial invader

People with viral infections and identical gene mutations may be prone to hyperinflammatory disorder

Risk of developing visceral leishmaniasis much higher in transplant patients

Infants below age 1 at risk of serious physical abuse

UNC study reveals how specific schizophrenia symptoms linked to distinct brain circuits

Therapeutic hypothermia after cardiac arrest improves survival and neurological outcomes

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News